Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1
- PMID: 11078559
- DOI: 10.1002/1096-8628(20001113)95:2<108::aid-ajmg4>3.0.co;2-0
Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1
Abstract
Although it is well recognized that a peripheral vasculopathy may occur in patients with neurofibromatosis 1 (NF1), it is unclear whether cardiovascular abnormalities are more common. We reviewed the frequency of cardiovascular abnormalities, in particular, cardiovascular malformations (CVMs), among 2322 patients with definite NF1 in the National Neurofibromatosis Foundation International Database from 1991-98. Cardiovascular malformations were reported in 54/2322 (2.3%) of the NF1 patients, only 4 of whom had Watson syndrome or NF1-Noonan syndrome. There was a predominance of Class II "flow" defects [Clark, 1995: Moss and Adams' Heart Disease in Infants, Children, and Adolescents Including the Fetus and Young Adult. p 60-70] (43/54, 80%) among the NF1 patients with CVMs. Pulmonic stenosis, that was present in 25 NF1 patients, and aortic coarctation, that occurred in 5, constitute much larger proportions of all CVMs than expected. Of interest was the paucity of Class I conotruncal defects (2 patients with tetralogy of Fallot), and the absence of atrioventricular canal, anomalous pulmonary venous return, complex single ventricle and laterality defects. Besides the 54 patients with CVMs, there were 27 patients with other cardiac abnormalities (16 with murmur, 5 with mitral valve prolapse, 1 with intracardiac tumor, and 5 with electrocardiogram abnormalities). No patient in this study had hypertrophic cardiomyopathy. There were 16 patients who had a peripheral vascular abnormality without an intracardiac CVM, plus an additional 4 patients among those with a CVM who also had a peripheral vascular abnormality.
Copyright 2000 Wiley-Liss, Inc.
Similar articles
-
Cardiac screening in pediatric patients with neurofibromatosis type 1: similarities with Noonan syndrome?Int J Cardiovasc Imaging. 2024 Jul;40(7):1475-1482. doi: 10.1007/s10554-024-03125-8. Epub 2024 May 13. Int J Cardiovasc Imaging. 2024. PMID: 38739321 Free PMC article.
-
Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis.Clin Genet. 1996 Feb;49(2):59-64. doi: 10.1111/j.1399-0004.1996.tb04328.x. Clin Genet. 1996. PMID: 8740913
-
Mitral valve prolapse in adults with congenital heart disease.Am Heart J. 1979 May;97(5):561-73. doi: 10.1016/0002-8703(79)90182-0. Am Heart J. 1979. PMID: 433730 No abstract available.
-
Cardiovascular malformations in Smith-Lemli-Opitz syndrome.Am J Med Genet. 1997 Jan 31;68(3):270-8. Am J Med Genet. 1997. PMID: 9024558 Review.
-
Neurovascular complications in adults with Neurofibromatosis type 1: A national referral center experience.Am J Med Genet A. 2022 Oct;188(10):3009-3015. doi: 10.1002/ajmg.a.62931. Epub 2022 Aug 10. Am J Med Genet A. 2022. PMID: 36097643 Review.
Cited by
-
Ruptured left external carotid artery aneurysm presenting as upper airway obstruction in von Recklinghausen's disease.Int J Surg Case Rep. 2016;26:170-2. doi: 10.1016/j.ijscr.2016.07.009. Epub 2016 Jul 14. Int J Surg Case Rep. 2016. PMID: 27518244 Free PMC article.
-
Activation of endothelial ras signaling bypasses senescence and causes abnormal vascular morphogenesis.Cancer Res. 2010 May 1;70(9):3803-12. doi: 10.1158/0008-5472.CAN-09-2648. Epub 2010 Apr 13. Cancer Res. 2010. PMID: 20388785 Free PMC article.
-
Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.Mol Genet Genomic Med. 2020 Apr;8(4):e1180. doi: 10.1002/mgg3.1180. Epub 2020 Feb 27. Mol Genet Genomic Med. 2020. PMID: 32107864 Free PMC article.
-
Ruptured Occipital Artery Aneurysm Following Craniotomy in a Patient with Neurofibromatosis Type 1: Case Report.J Neuroendovasc Ther. 2024;18(6):177-181. doi: 10.5797/jnet.cr.2023-0098. Epub 2024 Apr 16. J Neuroendovasc Ther. 2024. PMID: 38911485 Free PMC article.
-
Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.In Vivo. 2021 May-Jun;35(3):1711-1736. doi: 10.21873/invivo.12431. In Vivo. 2021. PMID: 33910856 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous